Insight into chromatin therapies for breast cancer could aid personalized medicine


(Boston University School of Medicine) Most traditional chemotherapy for cancer has dangerous side effects, but new research is finding ways to develop ‘targeted agents’ that reduce the side effects and are better tailored to individual patient needs. While these innovations are exciting, a new study shows how certain cancer inhibitors need to be examined more carefully to better understand fine-grained effects and counter-effects, which could yield more effective and safer therapies.